{
    "clinical_study": {
        "@rank": "75364", 
        "acronym": "EPIC", 
        "arm_group": [
            {
                "arm_group_label": "Eeva Test Group", 
                "description": "Day 3 embryo transfers that used Eeva predictions with morphology grading."
            }, 
            {
                "arm_group_label": "Matched case control group", 
                "description": "Day 3 embryo transfers using morphology grading only (from a matched concurrent control group)."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this postmarket study is to gather data to evaluate the impact of using Eeva\n      with traditional morphology grading on clinical pregnancy rates."
        }, 
        "brief_title": "Eeva\u2122 Pregnancy Investigational Clinical Study: A Postmarket Follow-Up Study", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "detailed_description": {
            "textblock": "The purpose of this postmarket study is to gather data to evaluate the impact of using Eeva\n      with traditional morphology grading on clinical pregnancy rates, as compared to a matched\n      case control group that used morphology grading only to select embryos for transfer."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women undergoing fresh in vitro fertilization treatment using their own  eggs or\n             donor eggs.\n\n          -  IVF cycle attempts \u2264 3.\n\n          -  Egg age \u2264 40 years.\n\n          -  Planned Day 3 embryo transfer.\n\n          -  At least 5 normally fertilized eggs (2PN).\n\n          -  All 2PN embryos must be imaged by Eeva.\n\n          -  Normal uterine cavity as evaluated by standard methods.\n\n          -  Fertilization using only ejaculated sperm (fresh or frozen) - no surgically removed\n             sperm.\n\n          -  Willing to comply with study protocol and procedures.\n\n          -  Willing to provide written informed consent.\n\n        Exclusion Criteria:\n\n          -  Planned preimplantation genetic diagnosis.\n\n          -  Planned \"freeze all\" cycle (oocytes or embryos).\n\n          -  Concurrent participation in another clinical study."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients undergoing in vitro fertilization treatment who provide informed consent and plan\n        to undergo Day 3 embryo transfer."
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01671644", 
            "org_study_id": "2012-AUX-005", 
            "secondary_id": "TST-1872-p"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "In vitro fertilization", 
            "Assisted reproductive therapy", 
            "Time-lapse image recording", 
            "Image analysis software"
        ], 
        "lastchanged_date": "February 11, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Gent", 
                        "country": "Belgium", 
                        "state": "East Flanders", 
                        "zip": "9000 Gent"
                    }, 
                    "name": "Gent University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "state": "South Holland", 
                        "zip": "2500 BH"
                    }, 
                    "name": "VU University Medical Center"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Netherlands"
            ]
        }, 
        "number_of_groups": "2", 
        "official_title": "Eeva\u2122 Pregnancy Investigational Clinical Study: A Postmarket Follow-Up Study", 
        "overall_official": {
            "affiliation": "Auxogyn, Inc.", 
            "last_name": "Shehua Shen, MD, ELD", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
                "Belgium: Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To compare the rate of clinical pregnancy  at approximately 5-8 weeks gestational age for the Day 3 embryo transfers that used Eeva predictions with morphology grading to that for Day 3 embryo transfers using morphology grading only (from a matched concurrent control group at each clinical site comprised of year 2011-2013 patients).", 
            "measure": "Rate of clinical pregnancy", 
            "safety_issue": "No", 
            "time_frame": "5-8 weeks gestational age"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01671644"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Implantation rate (# of implanted embryos out of # of total embryos transferred)", 
                "safety_issue": "No", 
                "time_frame": "5-8 weeks gestational age."
            }, 
            {
                "measure": "Ongoing Pregnancy Rate (gestational week 10-12)", 
                "safety_issue": "No", 
                "time_frame": "Gestational age week 10-12"
            }, 
            {
                "measure": "Multiple pregnancy rate", 
                "safety_issue": "No", 
                "time_frame": "Gestational weeks 5-8 and 10-12"
            }, 
            {
                "measure": "Spontaneous miscarriage rate", 
                "safety_issue": "No", 
                "time_frame": "Gestational age week 10-12"
            }
        ], 
        "source": "Auxogyn, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Auxogyn, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Observational Model: Case Control", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}